Gender as a Modifying Factor Influencing ...
Type de document :
Article dans une revue scientifique
PMID :
URL permanente :
Titre :
Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study
Auteur(s) :
Dogan, Celine [Auteur]
De Antonio, Marie [Auteur]
Hamroun, Dalil [Auteur]
Varet, Hugo [Auteur]
Fabbro, Marianne [Auteur]
Rougier, Felix [Auteur]
Amarof, Khadija [Auteur]
Arne Bes, Marie-Christine [Auteur]
Bedat-Millet, Anne-Laure [Auteur]
Béhin, Anthony [Auteur]
Bellance, Remi [Auteur]
Bouhour, Françoise [Auteur]
Boutte, Celia [Auteur]
Boyer, François-Constant [Auteur]
Salort-Campana, Emmanuelle [Auteur]
Chapon, Françoise [Auteur]
Cintas, Pascal [Auteur]
Desnuelle, Claude [Auteur]
Deschamps, Romain [Auteur]
Drouin-Garraud, Valerie [Auteur]
Ferrer, Xavier [Auteur]
Gervais-Bernard, Helene [Auteur]
Ghorab, Karima [Auteur]
Laforêt, Pascal [Auteur]
Magot, Armelle [Auteur]
Magy, Laurent [Auteur]
Menard, Dominique [Auteur]
Minot, Marie-Christine [Auteur]
Nadaj-Pakleza, Aleksandra [Auteur]
Pellieux, Sybille [Auteur]
Péréon, Yann [Auteur]
Preud'homme, Marguerite [Auteur]
Pouget, Jean [Auteur]
Sacconi, Sabrina [Auteur]
Solé, Guilhem [Auteur]
Stojkovic, Tanya [Auteur]
Tiffreau, Vincent [Auteur]
Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS) - ULR 7369 - ULR 4488 [URePSSS]
Urtizberea, Jon-Andoni [Auteur]
Vial, Christophe [Auteur]
Zagnoli, Fabien [Auteur]
Caranhac, Gilbert [Auteur]
Bourlier, Claude [Auteur]
Riviere, Gerard [Auteur]
Geille, Alain [Auteur]
Gherardi, Romain K [Auteur]
Eymard, Bruno [Auteur]
Puymirat, Jack [Auteur]
Katsahian, Sandrine [Auteur]
Bassez, Guillaume [Auteur]
De Antonio, Marie [Auteur]
Hamroun, Dalil [Auteur]
Varet, Hugo [Auteur]
Fabbro, Marianne [Auteur]
Rougier, Felix [Auteur]
Amarof, Khadija [Auteur]
Arne Bes, Marie-Christine [Auteur]
Bedat-Millet, Anne-Laure [Auteur]
Béhin, Anthony [Auteur]
Bellance, Remi [Auteur]
Bouhour, Françoise [Auteur]
Boutte, Celia [Auteur]
Boyer, François-Constant [Auteur]
Salort-Campana, Emmanuelle [Auteur]
Chapon, Françoise [Auteur]
Cintas, Pascal [Auteur]
Desnuelle, Claude [Auteur]
Deschamps, Romain [Auteur]
Drouin-Garraud, Valerie [Auteur]
Ferrer, Xavier [Auteur]
Gervais-Bernard, Helene [Auteur]
Ghorab, Karima [Auteur]
Laforêt, Pascal [Auteur]
Magot, Armelle [Auteur]
Magy, Laurent [Auteur]
Menard, Dominique [Auteur]
Minot, Marie-Christine [Auteur]
Nadaj-Pakleza, Aleksandra [Auteur]
Pellieux, Sybille [Auteur]
Péréon, Yann [Auteur]
Preud'homme, Marguerite [Auteur]
Pouget, Jean [Auteur]
Sacconi, Sabrina [Auteur]
Solé, Guilhem [Auteur]
Stojkovic, Tanya [Auteur]
Tiffreau, Vincent [Auteur]

Unité de Recherche Pluridisciplinaire Sport, Santé, Société (URePSSS) - ULR 7369 - ULR 4488 [URePSSS]
Urtizberea, Jon-Andoni [Auteur]
Vial, Christophe [Auteur]
Zagnoli, Fabien [Auteur]
Caranhac, Gilbert [Auteur]
Bourlier, Claude [Auteur]
Riviere, Gerard [Auteur]
Geille, Alain [Auteur]
Gherardi, Romain K [Auteur]
Eymard, Bruno [Auteur]
Puymirat, Jack [Auteur]
Katsahian, Sandrine [Auteur]
Bassez, Guillaume [Auteur]
Titre de la revue :
PLoS One
Nom court de la revue :
PLoS One
Numéro :
11
Date de publication :
2016-02-05
ISSN :
1932-6203
Mot(s)-clé(s) en anglais :
Mesh:Myotonic Dystrophy/epidemiology*
Mesh:Myotonic Dystrophy/mortality
Mesh:Adult
Mesh:Cross-Sectional Studies
Mesh:Databases
Mesh:Factual*
Mesh:Female
Mesh:Humans
Mesh:Sex Distribution
Mesh:Socioeconomic Factors
Mesh:Phenotype*
Mesh:Male
Mesh:Myotonic Dystrophy/mortality
Mesh:Adult
Mesh:Cross-Sectional Studies
Mesh:Databases
Mesh:Factual*
Mesh:Female
Mesh:Humans
Mesh:Sex Distribution
Mesh:Socioeconomic Factors
Mesh:Phenotype*
Mesh:Male
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
BACKGROUND: Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The ...
Lire la suite >BACKGROUND: Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The CTG expansion size is the main factor determining the age of onset although no factor can finely predict phenotype and prognosis. Differences between males and females have not been specifically reported. Our aim is to study gender impact on DM1 phenotype and severity. METHODS: We first performed cross-sectional analysis of main multiorgan clinical parameters in 1409 adult DM1 patients (>18 y) from the DM-Scope nationwide registry and observed different patterns in males and females. Then, we assessed gender impact on social and economic domains using the AFM-Téléthon DM1 survey (n = 970), and morbidity and mortality using the French National Health Service Database (n = 3301). RESULTS: Men more frequently had (1) severe muscular disability with marked myotonia, muscle weakness, cardiac, and respiratory involvement; (2) developmental abnormalities with facial dysmorphism and cognitive impairment inferred from low educational levels and work in specialized environments; and (3) lonely life. Alternatively, women more frequently had cataracts, dysphagia, digestive tract dysfunction, incontinence, thyroid disorder and obesity. Most differences were out of proportion to those observed in the general population. Compared to women, males were more affected in their social and economic life. In addition, they were more frequently hospitalized for cardiac problems, and had a higher mortality rate. CONCLUSIONS: Gender is a previously unrecognized factor influencing DM1 clinical profile and severity of the disease, with worse socio-economic consequences of the disease and higher morbidity and mortality in males. Gender should be considered in the design of both stratified medical management and clinical trials.Lire moins >
Lire la suite >BACKGROUND: Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The CTG expansion size is the main factor determining the age of onset although no factor can finely predict phenotype and prognosis. Differences between males and females have not been specifically reported. Our aim is to study gender impact on DM1 phenotype and severity. METHODS: We first performed cross-sectional analysis of main multiorgan clinical parameters in 1409 adult DM1 patients (>18 y) from the DM-Scope nationwide registry and observed different patterns in males and females. Then, we assessed gender impact on social and economic domains using the AFM-Téléthon DM1 survey (n = 970), and morbidity and mortality using the French National Health Service Database (n = 3301). RESULTS: Men more frequently had (1) severe muscular disability with marked myotonia, muscle weakness, cardiac, and respiratory involvement; (2) developmental abnormalities with facial dysmorphism and cognitive impairment inferred from low educational levels and work in specialized environments; and (3) lonely life. Alternatively, women more frequently had cataracts, dysphagia, digestive tract dysfunction, incontinence, thyroid disorder and obesity. Most differences were out of proportion to those observed in the general population. Compared to women, males were more affected in their social and economic life. In addition, they were more frequently hospitalized for cardiac problems, and had a higher mortality rate. CONCLUSIONS: Gender is a previously unrecognized factor influencing DM1 clinical profile and severity of the disease, with worse socio-economic consequences of the disease and higher morbidity and mortality in males. Gender should be considered in the design of both stratified medical management and clinical trials.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Univ. Littoral Côte d’Opale
Univ. Artois
Université de Lille
Univ. Artois
Université de Lille
Équipe(s) de recherche :
Activité Physique, Muscle, Santé (APMS)
Date de dépôt :
2019-09-24T10:02:13Z